www.fdanews.com/articles/185338-vizai-gets-ce-mark-for-artificial-intelligence-powered-stroke-care-system
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Vizai_Logo.gif?t=1516750506&width=430)
Viz.ai Gets CE Mark for Artificial Intelligence-Powered Stroke Care System
January 23, 2018
Viz.ai, a San Francisco-based developer of artificial intelligence imaging and workflow software, obtained a CE Mark for its ContaCT.
The device conducts automatic analyses of brain CT scans using deep learning algorithms, and sends notifications to specialists of large vessel occlusions.
Early intervention is critical in stroke treatment, and ContaCT is the first AI-based “direct-to-intervention” system, according to the company.